Priyam Mitra

643 total citations
5 papers, 383 citations indexed

About

Priyam Mitra is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Priyam Mitra has authored 5 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Molecular Biology. Recurrent topics in Priyam Mitra's work include Cancer Immunotherapy and Biomarkers (2 papers), Cancer therapeutics and mechanisms (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). Priyam Mitra is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Cancer therapeutics and mechanisms (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). Priyam Mitra collaborates with scholars based in United States, Austria and Finland. Priyam Mitra's co-authors include Ignacio Melero, Carlos Gomez‐Roca, Shailender Bhatia, Satyendra Suryawanshi, Petri Bono, Marta Nyakas, Paolo A. Ascierto, F. Stephen Hodi, Margaret K. Callahan and Rachel E. Sanborn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Priyam Mitra

5 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priyam Mitra United States 3 322 211 63 50 49 5 383
Milan Sandhu United States 3 201 0.6× 172 0.8× 70 1.1× 44 0.9× 27 0.6× 4 330
David Agdashian United States 4 201 0.6× 174 0.8× 74 1.2× 44 0.9× 27 0.6× 6 343
Rikke B. Holmstroem Denmark 6 197 0.6× 143 0.7× 61 1.0× 21 0.4× 18 0.4× 10 280
Ricky Patel United States 2 111 0.3× 110 0.5× 139 2.2× 66 1.3× 78 1.6× 5 316
Juan‐Manuel Hernandez‐Martinez Mexico 6 168 0.5× 164 0.8× 71 1.1× 68 1.4× 8 0.2× 13 318
Shuang Mo China 7 81 0.3× 48 0.2× 218 3.5× 60 1.2× 19 0.4× 7 312
Ka‐Wo Chan China 7 127 0.4× 144 0.7× 190 3.0× 45 0.9× 10 0.2× 8 376
Larisa Ryvo Israel 8 239 0.7× 76 0.4× 68 1.1× 83 1.7× 2 0.0× 13 312
Mélanie Buchi Switzerland 5 133 0.4× 92 0.4× 67 1.1× 30 0.6× 2 0.0× 6 224
Huiyan Cheng China 7 75 0.2× 117 0.6× 169 2.7× 41 0.8× 3 0.1× 10 321

Countries citing papers authored by Priyam Mitra

Since Specialization
Citations

This map shows the geographic impact of Priyam Mitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priyam Mitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priyam Mitra more than expected).

Fields of papers citing papers by Priyam Mitra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priyam Mitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priyam Mitra. The network helps show where Priyam Mitra may publish in the future.

Co-authorship network of co-authors of Priyam Mitra

This figure shows the co-authorship network connecting the top 25 collaborators of Priyam Mitra. A scholar is included among the top collaborators of Priyam Mitra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priyam Mitra. Priyam Mitra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Punekar, Salman R., Jia Luo, S-H.I. Ou, et al.. (2025). 6MO: Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 20(3). S10–S11. 1 indexed citations
2.
Mitra, Priyam, et al.. (2021). Multi-arm multi-stage clinical trials for time-to-event outcomes. Journal of Biopharmaceutical Statistics. 31(6). 838–851. 1 indexed citations
3.
4.
5.
Ascierto, Paolo A., Ignacio Melero, Shailender Bhatia, et al.. (2017). Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy.. Journal of Clinical Oncology. 35(15_suppl). 9520–9520. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milan Sandhu Breakdown of academic impact, for papers by David Agdashian Breakdown of academic impact, for papers by Rikke B. Holmstroem Breakdown of academic impact, for papers by Ricky Patel Breakdown of academic impact, for papers by Juan‐Manuel Hernandez‐Martinez Breakdown of academic impact, for papers by Shuang Mo Breakdown of academic impact, for papers by Ka‐Wo Chan Breakdown of academic impact, for papers by Larisa Ryvo Breakdown of academic impact, for papers by Mélanie Buchi Breakdown of academic impact, for papers by Huiyan Cheng
Rankless by CCL
2026